Management of the overweight patient with Type 2 diabetes

Diabet Med. 2003 Sep:20 Suppl 4:10-3. doi: 10.1046/j.1464-5491.2003.00015.x.
No abstract available

MeSH terms

  • Anti-Obesity Agents / therapeutic use
  • Cyclobutanes / therapeutic use
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Lactones / therapeutic use
  • Metformin / therapeutic use
  • Middle Aged
  • Obesity / drug therapy
  • Obesity / etiology*
  • Orlistat
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Sulfonylurea Compounds / therapeutic use

Substances

  • Anti-Obesity Agents
  • Cyclobutanes
  • Hypoglycemic Agents
  • Lactones
  • Serotonin Uptake Inhibitors
  • Sulfonylurea Compounds
  • Metformin
  • Orlistat
  • sibutramine